House China panel probes Bristol Myers, Pfizer over clinical trial sites tied to the Chinese military and Xinjiang amid scrutiny of pharma's China ties.
A congressional committee has opened an inquiry into Bristol Myers Squibb and Pfizer’s use of clinical trial sites in China, including facilities that the committee’s …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
US House committee opens investigations into five drugmakers over clinical trials in China
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report - Merck & Co (NYSE:MRK), AbbVie
In Depth: U.S.’ Biotech Scrutiny Tests China’s Drugmakers Abroad
The U.S.-China biotech crackdown may hurt the scientists America needs the most
Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more
Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
At BIO, tension over China biotech deal regulation looms
